News
Media
Around the PracticeBetween The LinesCase-Based Peer PerspectiveClinical Case CollectiveDermViewExpert PerspectivesFellows Face OffFrontline ForumMedical World NewsPatient PerspectivesPodcastsReadout360Recognize and Refer
Conferences
Conference CoverageConference Listing
Events
Case-Based Roundtable
Publication
Dermatology Times
More
CME/CE
Resources
DermIQInteractive ToolsJob BoardPartner PerspectivesPerspectives in DermatologyPollsSponsored ContentSponsored ResourcesSpot Test
Editorial Advisory Board
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Publication
  • CME/CE
  • Resources
  • Editorial Advisory Board
  • Partners
  • Subscribe
  • Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
    • Biologic Treatments for Moderate to Severe Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
    • Emerging Therapies Plaque Psoriasis
    • Treatments for Plaque Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
    • Skin Cancer (Nonmelanoma)
  • Vitiligo
  • Wound Care
Advertisement

Paul Yamauchi, MD, PhD

Advertisement

Articles by Paul Yamauchi, MD, PhD

New Research Confirms Effective Therapy for Nail Psoriasis

ByMaddi Hebebrand, MC, Associate Editor,Paul Yamauchi, MD, PhD
March 20th 2025

Nail psoriasis affects 50% of plaque psoriasis patients, making effective treatments crucial.

Advertisement

Latest Updated Articles

  • New Research Confirms Effective Therapy for Nail Psoriasis
    New Research Confirms Effective Therapy for Nail Psoriasis

    Published: March 20th 2025 | Updated:



Advertisement
Advertisement

Trending on Dermatology Times

1

Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results

2

Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott

3

Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic

4

Dermatology Conferences and Meetings Calendar: December 2025

5

ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN

  • About
  • Advertise
  • Contact Us
  • Job Board
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy Policy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us